These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2210 related items for PubMed ID: 32559140

  • 1. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S, Peng F, Li ML, Duan WB, Peng CQ, Wu SJ.
    Am J Physiol Heart Circ Physiol; 2020 Aug 01; 319(2):H377-H391. PubMed ID: 32559140
    [Abstract] [Full Text] [Related]

  • 2. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
    Xu Y, Sun Z, Wang Q, Wang T, Liu Y, Yu F.
    Vascul Pharmacol; 2019 Sep 01; 120():106568. PubMed ID: 31207359
    [Abstract] [Full Text] [Related]

  • 3. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y, Zhang Z, Zhang L, Chen S, Guo Y, Hong Y.
    Cardiovasc Pathol; 2018 Sep 01; 37():15-25. PubMed ID: 30195228
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
    Wang XY, Mo D, Tian W, Liu XX, Zhou YG, Sun Y, Feng YD, Xiao X, Hao XW, Zhang HN, Li C, Cao W, Li XQ.
    Toxicol Appl Pharmacol; 2019 Apr 15; 369():60-72. PubMed ID: 30831131
    [Abstract] [Full Text] [Related]

  • 5. LncRNA PAXIP1-AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis.
    Song R, Lei S, Yang S, Wu SJ.
    J Cell Mol Med; 2021 Aug 15; 25(15):7321-7334. PubMed ID: 34245091
    [Abstract] [Full Text] [Related]

  • 6. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
    Miao R, Liu W, Qi C, Song Y, Zhang Y, Fu Y, Liu W, Lang Y, Zhang Y, Zhang Z.
    Life Sci; 2020 Sep 15; 257():117919. PubMed ID: 32585247
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y, Yin L, Zhu M, Song S, Sun C, Han X, Xu Y, Zhao Y, Qi Y, Xu L, Peng JY.
    Biomed Pharmacother; 2021 Jan 15; 133():111056. PubMed ID: 33378960
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X, Chen Y, Tan J, Dai Y, Mao W, Qin G, Ye S, Sun J, Yang Z, Chen J.
    Vascul Pharmacol; 2019 May 15; 116():24-35. PubMed ID: 28694128
    [Abstract] [Full Text] [Related]

  • 9. Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis.
    Zhang S, Liu J, Zheng K, Chen L, Sun Y, Yao Z, Sun Y, Lin Y, Lin K, Yuan L.
    Vascul Pharmacol; 2021 Feb 15; 136():106820. PubMed ID: 33238205
    [Abstract] [Full Text] [Related]

  • 10. Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Factor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells.
    Li Y, Li L, Qian Z, Lin B, Chen J, Luo Y, Qu J, Raj JU, Gou D.
    J Am Heart Assoc; 2018 Mar 07; 7(6):. PubMed ID: 29514810
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.
    Zhang X, Qin H, Ma Q, Zhang J, Tian H, Meng Y.
    Clin Respir J; 2024 May 07; 18(5):e13771. PubMed ID: 38747117
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. miR-205-5p suppresses pulmonary vascular smooth muscle cell proliferation by targeting MICAL2-mediated Erk1/2 signaling.
    Tao W, Sun W, Zhu H, Zhang J.
    Microvasc Res; 2019 Jul 07; 124():43-50. PubMed ID: 30853343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effects of 18β-glycyrrhetinic acid on pulmonary arterial hypertension via regulation of Rho A/Rho kinsase pathway.
    Zhang M, Chang Z, Zhang P, Jing Z, Yan L, Feng J, Hu Z, Xu Q, Zhou W, Ma P, Hao Y, Zhou R.
    Chem Biol Interact; 2019 Sep 25; 311():108749. PubMed ID: 31325423
    [Abstract] [Full Text] [Related]

  • 18. Serotonin and chronic hypoxic pulmonary hypertension activate a NADPH oxidase 4 and TRPM2 dependent pathway for pulmonary arterial smooth muscle cell proliferation and migration.
    Song JL, Zheng SY, He RL, Gui LX, Lin MJ, Sham JSK.
    Vascul Pharmacol; 2021 Jun 25; 138():106860. PubMed ID: 33794383
    [Abstract] [Full Text] [Related]

  • 19. Long-Chain Non-Coding RNA Metastasis-Related Lung Adenocarcinoma Transcript 1 (MALAT1) Promotes the Proliferation and Migration of Human Pulmonary Artery Smooth Muscle Cells (hPASMCs) by Regulating the MicroRNA-503 (miR-503)/Toll-Like Receptor 4 (TLR4) Signal Axis.
    He M, Shen J, Zhang C, Chen Y, Wang W, Tao K.
    Med Sci Monit; 2020 Jul 13; 26():e923123. PubMed ID: 32712618
    [Abstract] [Full Text] [Related]

  • 20. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL, Wu ZJ, Liu XR, Gui LX, Wang RX, Lin MJ.
    Cell Physiol Biochem; 2018 Jul 13; 49(1):172-189. PubMed ID: 30134231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 111.